AAAAAA
Results: 1-25/29
Authors:
EHRKE MJ
VERSTOVSEK S
UJHAZY P
MEER JM
EPPOLITO C
MACCUBBIN DL
MIHICH E
Citation: Mj. Ehrke et al., DOXORUBICIN PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENTS IN EL4-LYMPHOMA-BEARING C57BL 6 MICE/, Cancer immunology and immunotherapy, 45(6), 1998, pp. 287-298
Authors:
EHRKE MJ
VERSTOVSEK S
POCCHIARI SK
KRAWCZYK CM
UJHAZY P
ZALESKIS G
MACCUBBIN DL
MEER JM
MIHICH E
Citation: Mj. Ehrke et al., THYMIC ANTITUMOR EFFECTORS IN MICE CURED OF LYMPHOMA BY CYCLOPHOSPHAMIDE PLUS TNF-ALPHA THERAPY - PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION UP TO 20 MONTHS AFTER INITIAL TUMOR INOCULATION, International journal of cancer, 76(4), 1998, pp. 579-586
Authors:
MIHICH E
NICHOL CA
Citation: E. Mihich et Ca. Nichol, ROSWELL-PARK-CANCER-INSTITUTE SYMPOSIUM - MOLECULAR APPROACHES TO CANCER THERAPEUTICS, Cancer research, 57(22), 1997, pp. 5185-5188
Authors:
MIHICH E
HARTWELL L
Citation: E. Mihich et L. Hartwell, 8TH ANNUAL PEZCOLLER-SYMPOSIUM - GENOMIC INSTABILITY AND IMMORTALITY IN CANCER, Cancer research, 57(19), 1997, pp. 4437-4441
Authors:
MIHICH E
Citation: E. Mihich, DEVELOPMENT OF SYNTHETIC IMMUNOADJUVANTS AS CYTOKINE INDUCERS FOR CANCER-THERAPY, Japanese journal of cancer research, 87(7), 1996, pp. 2-2
SPECIFIC ANTI-EL4-LYMPHOMA IMMUNITY IN MICE CURED 2 YEARS EARLIER WITH DOXORUBICIN AND INTERLEUKIN-2
Authors:
EHRKE MJ
VERSTOVSEK S
ZALESKIS G
HO RLX
UJHAZY P
MACCUBBIN DL
MIHICH E
Citation: Mj. Ehrke et al., SPECIFIC ANTI-EL4-LYMPHOMA IMMUNITY IN MICE CURED 2 YEARS EARLIER WITH DOXORUBICIN AND INTERLEUKIN-2, Cancer immunology and immunotherapy, 42(4), 1996, pp. 221-230
Authors:
MIHICH E
MORAN RG
NICHOL CA
Citation: E. Mihich et al., A TRIBUTE TO DR GRINDEY,GERALD,BURR, 1940-1993, Investigational new drugs, 14(3), 1996, pp. 241-242
Authors:
UJHAZY P
BERLETH ES
PIETKIEWICZ JM
KITANO H
SKAAR JR
EHRKE MJ
MIHICH E
Citation: P. Ujhazy et al., EVIDENCE FOR THE INVOLVEMENT OF ECTO-5-NUCLEOTIDASE (CD73) IN DRUG-RESISTANCE, International journal of cancer, 68(4), 1996, pp. 493-500
Authors:
MIHICH E
HOUSMAN D
Citation: E. Mihich et D. Housman, 7TH ANNUAL PEZCOLLER-SYMPOSIUM - CANCER GENES - FUNCTIONAL-ASPECTS, Cancer research, 56(18), 1996, pp. 4282-4287
Authors:
ZALESKIS G
VERSTOVSEK S
TZAI TS
MIHICH E
EHRKE MJ
Citation: G. Zaleskis et al., DOXORUBICIN AND CYCLOSPORINE-A AFFECT MURINE LYMPHOID-CELLS EXPRESSING DIFFERENT ANTIGENIC DETERMINANTS, Oncology research, 7(6), 1995, pp. 307-315
Authors:
VERSTOVSEK S
CASEY C
MIHICH E
EHRKE MJ
Citation: S. Verstovsek et al., INTERLEUKIN-2 ACTIVATED SPLENIC NK-1.1 NEGATIVE ADHERENT MACROPHAGES LYSE NATURAL-KILLER SENSITIVE YAC-1 TUMOR-CELLS IN 4 HOURS, The FASEB journal, 9(4), 1995, pp. 1040-1040
Authors:
VERSTOVSEK S
EPPOLITO C
UJHAZY P
MACCUBBIN DL
EHRKE MJ
MIHICH E
Citation: S. Verstovsek et al., MURINE SPLENIC MACROPHAGE TUMORICIDAL ACTIVATION BY CYTOKINES, Experimental hematology, 23(6), 1995, pp. 519-528
Authors:
EHRKE MJ
VERSTOVSEK S
KRAWCZYK CM
UJHAZY P
ZALESKIS G
MACCUBBIN DL
MIHICH E
Citation: Mj. Ehrke et al., CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA CHEMOIMMUNOTHERAPY CURED MICE - LIFELONG IMMUNITY AND REJECTION OF RE-IMPLANTED PRIMARY LYMPHOMA, International journal of cancer, 63(3), 1995, pp. 463-471
Authors:
MIHICH E
METCALF D
Citation: E. Mihich et D. Metcalf, 6TH ANNUAL PEZCOLLER-SYMPOSIUM - NORMAL AND MALIGNANT HEMATOPOIESIS -NEW ADVANCES, Cancer research, 55(15), 1995, pp. 3462-3466
Authors:
UJHAZY P
MACCUBBIN D
EPPOLITO C
MIHICH E
EHRKE MJ
Citation: P. Ujhazy et al., TNF-ALPHA POTENTIATION OF THE LYMPHOKINE-ACTIVATED KILLER RESPONSE OFMURINE THYMUS-CELLS, Lymphokine and cytokine research, 13(2), 1994, pp. 99-106
Authors:
ZALESKIS G
HO RLX
DIEGELMAN P
MACCUBBIN D
UJHAZY P
MIHICH E
EHRKE MJ
Citation: G. Zaleskis et al., INTRACELLULAR DOXORUBICIN KINETICS IN LYMPHOMA-CELLS AND LYMPHOCYTES INFILTRATING THE TUMOR AREA IN-VIVO - A FLOW CYTOMETRIC STUDY, Oncology research, 6(4-5), 1994, pp. 183-194
Authors:
MIHICH E
SCHIMKE RT
Citation: E. Mihich et Rt. Schimke, APOPTOSIS - 5TH PEZCOLLER-FOUNDATION SYMPOSIUM, TRENTO, ITALY, JUNE 9-11, 1993, European journal of cancer, 30A(2), 1994, pp. 232-234
Authors:
MIHICH E
SCHIMKE RT
Citation: E. Mihich et Rt. Schimke, APOPTOSIS - 5TH PEZCOLLER-FOUNDATION SYMPOSIUM - TRENTO, ITALY, JUNE 9-11, 1993, Annals of oncology, 5(2), 1994, pp. 119-121
Authors:
VERSTOVSEK S
ZALESKIS G
MACCUBBIN DL
MIHICH E
EHRKE MJ
Citation: S. Verstovsek et al., LIPOPOLYSACCHARIDE AND SPLENIC TUMORICIDAL MACROPHAGE ACTIVATION, Journal of leukocyte biology, 56(6), 1994, pp. 714-722
Authors:
BERLETH ES
DOLNICK BJ
EHRKE MJ
MIHICH E
Citation: Es. Berleth et al., RNA RECOVERY EFFICIENCY FOR CULTURED-CELLS AND ORGAN-DERIVED CELL-SUSPENSIONS, Nucleic acids research, 22(10), 1994, pp. 1925-1927
Authors:
ZALESKIS G
BERLETH E
VERSTOVSEK S
EHRKE MJ
MIHICH E
Citation: G. Zaleskis et al., DOXORUBICIN-INDUCED DNA-DEGRADATION IN MURINE THYMOCYTES, Molecular pharmacology, 46(5), 1994, pp. 901-908
Authors:
TZAI TS
HUBEN RP
ZALESKIS G
BERLETH ES
EHRKE MJ
MIHICH E
Citation: Ts. Tzai et al., EFFECT OF PERIOPERATIVE CHEMOIMMUNOTHERAPY WITH CYCLOPHOSPHAMIDE AND AUTOLOGOUS TUMOR VACCINE IN MURINE MBT-2 BLADDER-CANCER, The Journal of urology, 151(6), 1994, pp. 1680-1686
Authors:
UJHAZY P
KLOBUSICKA M
BABUSIKOVA O
STRAUSBAUCH P
MIHICH E
EHRKE MJ
Citation: P. Ujhazy et al., ECTO-5'-NUCLEOTIDASE (CD73) IN MULTIDRUG-RESISTANT CELL-LINES GENERATED BY DOXORUBICIN, International journal of cancer, 59(1), 1994, pp. 83-93
Authors:
SCHIMKE RT
MIHICH E
Citation: Rt. Schimke et E. Mihich, 5TH ANNUAL PEZCOLLER SYMPOSIUM - APOPTOSIS, Cancer research, 54(1), 1994, pp. 302-305
Authors:
HO RLX
MACCUBBIN DL
UJHAZY P
ZALESKIS G
EPPOLITO C
MIHICH E
EHRKE MJ
Citation: Rlx. Ho et al., IMMUNOLOGICAL RESPONSES CRITICAL TO THE THERAPEUTIC EFFECTS OF ADRIAMYCIN PLUS INTERLEUKIN-2 IN C57BL 6 MICE BEARING SYNGENEIC EL4 LYMPHOMA/, Oncology research, 5(9), 1993, pp. 363-372